ADVFN ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Premium Iconプレミアム Help Menu
Bitcoin
111,150.05
-0.12%
S&P 500
6,263.26
0.61%
Dow Jones
44,458.30
0.49%
US Dollar vs Yen
146.276
0.08%
Brent Oil
69.81
0.11%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Bone Biologics Corporation (BBLG)

  7. Bone Biologics Corporation (BBLG) ニュース

BBLG

Bone Biologics (BBLG)

Bone Biologics Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:BBLG
日付受信時刻ニュースソース見出しコード企業名
2025/07/0105 : 10Business WireBone Biologics Announces Closing of $5.0 Million Public OfferingNASDAQ:BBLGBone Biologics Corporation
2025/06/2722 : 10Business WireBone Biologics Announces Pricing of $5.0 Million Public OfferingNASDAQ:BBLGBone Biologics Corporation
2025/06/2720 : 00Business WireBone Biologics Files Patent Application for Bone Regeneration TechnologyNASDAQ:BBLGBone Biologics Corporation
2025/06/2705 : 20Business WireBone Biologics Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:BBLGBone Biologics Corporation
2025/06/0621 : 00Business WireBone Biologics Announces 1-for-6 Reverse Stock SplitNASDAQ:BBLGBone Biologics Corporation
2024/10/2121 : 00Business WireBone Biologics Appoints Phillip T. Meikle to its Board of DirectorsNASDAQ:BBLGBone Biologics Corporation
2024/09/0421 : 00Business WireBone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:BBLGBone Biologics Corporation
2024/08/2713 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BBLGBone Biologics Corporation
2024/08/1306 : 00Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BBLGBone Biologics Corporation
2024/08/0821 : 10Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:BBLGBone Biologics Corporation
2024/08/0821 : 05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BBLGBone Biologics Corporation
2024/08/0821 : 00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BBLGBone Biologics Corporation
2024/08/0221 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BBLGBone Biologics Corporation
2024/08/0221 : 00Business WireBone Biologics Announces Exercise of Warrants for $2.1 Million Gross ProceedsNASDAQ:BBLGBone Biologics Corporation
2024/06/2121 : 35GlobeNewswire Inc.Life Science Virtual Investor Forum Presentations Now Available for Online ViewingNASDAQ:BBLGBone Biologics Corporation
2024/03/0706 : 15Business WireBone Biologics Announces Closing of $2.0 Million Public OfferingNASDAQ:BBLGBone Biologics Corporation
2024/03/0514 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BBLGBone Biologics Corporation
2024/03/0507 : 21Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BBLGBone Biologics Corporation
2024/03/0423 : 15Business WireBone Biologics Announces Pricing of $2.0 Million Public OfferingNASDAQ:BBLGBone Biologics Corporation
2024/03/0122 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BBLGBone Biologics Corporation
2024/03/0122 : 00Business WireBone Biologics Reports Progress With NB1 Clinical ProgramNASDAQ:BBLGBone Biologics Corporation
2024/02/2706 : 50Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BBLGBone Biologics Corporation
2024/02/2407 : 09Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BBLGBone Biologics Corporation
2024/02/2207 : 05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BBLGBone Biologics Corporation
2024/02/1508 : 41Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BBLGBone Biologics Corporation
2024/02/1500 : 55Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BBLGBone Biologics Corporation
2024/02/1410 : 03Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BBLGBone Biologics Corporation
2024/01/3107 : 09Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BBLGBone Biologics Corporation
2024/01/2514 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BBLGBone Biologics Corporation
2024/01/2007 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BBLGBone Biologics Corporation
 Showing the most relevant articles for your search:NASDAQ:BBLG

最近閲覧した銘柄

USOTC
RHHBY
Roche (QX)
NYSE
VZ
Verizon Communications
NYSE
BAC
Bank of America
NYSE
MCD
McDonalds
NASDAQ
TSLA
Tesla
CCOM
SILVER
SILVER
NYSE
KO
Coca Cola
AMEX
SPY
SPDR S&P 500
NYSE
DIS
Walt Disney
COIN
XRPUSD
Ripple
NYSE
XOM
Exxon Mobil
AMEX
XLV
Health Care Select Sector
SPI
SP500
S&P 500
PM
XAUUSD
Gold vs US Dollar
COIN
SOLUSD
Solana
COIN
AVAXUSD
Avalanche
Delayed Upgrade Clock
ADVFN
日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN Ltd - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す